Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
J INTS BIO successfully held two Korean Advisory Board Meetings for its Novel Oral 4th Generation EGFR TKI (JIN-A02) 2022-06-10 17:00
RAD adds brain tumor technology to portfolio 2022-06-10 10:21
Inteleos Announces Maya Health Alliance as MissionPOCUS Selection for 2022 2022-06-09 22:09
BIORCHESTRA, presenting lead candidate BMD-001 for Alzheimer's disease and drug delivery system technology at the 2022 BIO International Convention 2022-06-09 20:30
Health Canal Appoints New Formal Owner In Efforts To Become Global Leader In Medical Health News 2022-06-09 15:40
Standigm Signs MOU with Merck Korea for AI drug Discovery Research 2022-06-09 14:46
Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board 2022-06-09 00:05
OnCusp Therapeutics and Multitude Therapeutics Enter into an Ex-China Licensing Agreement for a Potentially Highly Differentiated CDH6-Targeting Antibody Drug Conjugate 2022-06-08 20:00
Harbour BioMed Announces IND Approval for B7H4x4-1BB Bispecific Antibody 2022-06-08 18:11
Waterdrop Inc. to Report First Quarter 2022 Financial Results on June 15, 2022 2022-06-08 17:11
ASCO 2022 | Ascentage Pharma Releases Updated Data Demonstrating Lisaftoclax's (APG-2575) Therapeutic Potential in Patients with R/R CLL/SLL 2022-06-08 08:00
ASCO 2022 | Ascentage Pharma Releases for the First Time Results of its FAK/ALK/ROS1 inhibitor APG-2449 Demonstrating Safety and Efficacy in Patients with Advanced NSCLC 2022-06-08 08:00
Snap Fitness Announces "Earn Your Apple Watch" Program 2022-06-08 06:00
The 3rd BIO International Convention 2022 is Approaching 2022-06-07 19:23
PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT 2022-06-07 19:00
Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting 2022-06-07 14:00
ASCO 2022 | Ascentage Pharma Releases Updated Results Demonstrating the Therapeutic Potential of Alrizomadlin (APG-115) plus Pembrolizumab in Patients with Solid Tumors who Progressed on Immunotherapies 2022-06-07 11:30
ASCO 2022 | The First Dataset of Olverembatinib (HQP1351) in Patients with GIST Demonstrates Therapeutic Potential with a Clinical Benefit Rate of 83.3% 2022-06-07 11:28
iNtRON Completes GLP-TOX Studies of BAL200 2022-06-07 09:00
MGI Announces Commercial Availability of DNBSEQ™ Sequencers* in the United States 2022-06-07 00:59
1 143 144 145 146 147 801